News

Check out our latest stories

Octapharma USA: <em>JAMA</em> Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding

Strengthening future growth

Built on strength and resilience

Octapharma USA Receives FDA Emergency Use Authorization for octaplasLG Powder, Allows U.S. Military Medical Providers Emergent Use in Treatment of Hemorrhage or Coagulopathy

Patient engagement

Octapharma takes an active role in the communities in which people rely on us for their medicines. 

Patient engagement 

Octapharma takes an active role within the communities of people who rely on us for their medicines. We sponsor and support organizations worldwide.

Octapharma takes an active role in our community

Products

Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders.

Products 

Octapharma 

About us

Our passion drives us to provide new health solutions advancing human life.

[YOUR MESSAGE]%0D%0A%0D%0A%0D%0ALocation: ${location}%0D%0A%0D%0AReport:%0D%0A${report}

black (do not use in pages!!)

white (do not use in pages!!)

octaBlue (do not use in pages!!)

azure

green

orange

rose

turquoise

umbra

yellow

atenativ

octaplasLG

albunorm

fibryga

octaplex

gammanorm

cutaquiq

reshonativ

octagam

panzyga

nuwiq

octanineF

wilate

octanate

About us

Check out our latest stories

Octapharma USA: JAMA Publishes Results for Investigational Four-Factor Prothrombin Complex Concentrate in Cardiac Surgical Bleeding

Strengthening future growth

Built on strength and resilience

Octapharma USA Receives FDA Emergency Use Authorization for octaplasLG Powder, Allows U.S. Military Medical Providers Emergent Use in Treatment of Hemorrhage or Coagulopathy

Octapharma takes an active role in our community

Products

About us

Plasma

Products

Engagement

News